Abstract
Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 816-818 |
| Number of pages | 3 |
| Journal | Journal of Inherited Metabolic Disease |
| Volume | 26 |
| Issue number | 8 |
| DOIs | |
| State | Published - 2003 |
| Externally published | Yes |
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)
Fingerprint Dive into the research topics of 'Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy'. Together they form a unique fingerprint.
Cite this
Hong, Y. S., Korman, S. H., Lee, J., Ghoshal, P., Wu, Q., Barash, V., Kang, S., Oh, S., Kwon, M., Gutman, A., Rachmel, A., & Patel, M. S. (2003). Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy. Journal of Inherited Metabolic Disease, 26(8), 816-818. https://doi.org/10.1023/B:BOLI.0000010004.12053.5b